Public-private partnerships offer a promising alternative paradigm for pharmaceutical innovation in complex disease … essential to accelerate pharmaceutical innovation. Patents threaten the potential of partnership strategies, however, by making … innovation is fundamentally flawed for two reasons. First, it ignores the competitive market pressures that both shape what is …

identifying and eliminating import dependencies in the field of pharmaceuticals. HERA’s work thus aligns with current EU efforts …

-containment measures and innovation issues is performed, then in the second chapter, an empirical study is performed to investigate … price for off-patent markets can contribute in promoting innovation. Finally, in the fourth chapter, the modeling of risk …